Safely Transition Patients Taking the New Nebulized Med Yupelri at Home

April 2019

You'll see Yupelri (yoo-PEL-ree, revefenacin), the first ONCE-daily nebulized long-acting muscarinic antagonist (LAMA) for COPD....

Exclusive Subscriber Content

Best in class medication learning
Concise recommendations
Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login

Table of Contents

Surgery Tailor Enhanced Recovery After Surgery (ERAS) Protocols to Your Hospital's Needs
Anticoagulants Add DOACs to Your List of Options for Treating HIT
Infectious Diseases Update Your Colistin and Polymyxin B Protocols
Measles Be Prepared if a Measles Outbreak Brings Patients to Your Hospital
Edema Look for Medication Causes of Peripheral Edema
Anxiety Think of Buspirone as a Second-Line Option for Managing Anxiety
Epinephrine Be Aware of Differences Between Symjepi and Epinephrine Auto-Injectors
Hyperkalemia Know When to Choose One Potassium Binder Over Another
New Drugs Safely Transition Patients Taking the New Nebulized Med Yupelri at Home